Corcept Therapeutics Incorporated
CORT News Today: Stay Updated with the Latest Corcept Therapeutics Incorporated News in Real Time
Find CORT news now at Meyka AI. Stay informed with the latest Corcept Therapeutics Incorporated stocks updates, including price news, market analysis, and expert insights.
ITRM Iterum Therapeutics plc NASDAQ Q4 2025 results 03 Apr 2026: Earnings drivers and outlook
ITRM stock closed at $0.03 on 03 Apr 2026 after Q4 2025 results. Read Meyka AI earnings spotlight and short-term outlook for ITRM stock
6255.T stock JPY 770.00 pre-market ahead of 04 Apr 2026 earnings: EPS in focus
Pre-market update on 6255.T stock at JPY 770.00 ahead of April 8 earnings; EPS and guidance in focus
BTIG Maintains ALDX (Aldeyra Therapeutics) at Buy on Mar 17, 2026
BTIG maintains Buy on ALDX; ALDX analyst rating reviewed after Mar 17, 2026 note
Pre-Market: MMTX.SW stock rises 8.02% on SIX, watch volume for follow-through
MMTX.SW stock climbs 8.02% pre-market on SIX to CHF 0.35; technical oversold signals and Meyka AI forecast highlight near-term upside
Jefferies Maintains Buy for CTMX (CytomX Therapeutics) March 18, 2026
Jefferies maintained Buy on CTMX March 18, 2026. Read CTMX analyst rating, $16 PT, and Meyka AI grade B+
William Blair: Market Perform for CSL (Carlisle Companies Incorporated) Mar 2026
William Blair maintained Market Perform on CSL. CSL analyst rating update March 2026
Jefferies Maintains Buy on Protagonist Therapeutics (PTGX) PT $121 Mar 2026
PTGX analyst rating update: Jefferies, Johnson Rice maintain Buy; PT $121 and royalty model cited
BofA Unveils 10 US Stock Picks for Q2 as Market Pullback Creates Opportunities
As the US equity market experiences a mild pullback in early 2026, BofA analysts are highlighting opportunities for long‑term investors. BofA has released a new set of 10 recommended US stocks that it believes could benefit from current valuations and broader economic trends. These picks reflect strong fundamentals, sector growth potential, and positioning in future‑oriented…
4840.T stock up 34.01% to JPY 788 on JPX Apr 2026: high volume momentum
Market closed: 4840.T stock rose 34.01% to JPY 788 on JPX Apr 2026 on heavy volume and overbought technicals